Physician profile
Jeffrey B Witty
NPI 1013178284
$7,916.59
in general payments reported to CMS, 2019-2025
13 companies · $182 in 2025
The $182 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,549 · 2020: $779 · 2021: $45.43 · 2022: $49.45 · 2023: $1,421 · 2024: $1,891 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,321 · Food and Beverage: $1,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,320.62 |
| Food and Beverage | $1,172.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $3,348.99 | 2019-2024 | |
| Arthrex, INC. | $2,214.30 | 2019-2024 | |
| Depuy Synthes Sales INC. | $927.92 | 2023 | |
| Stryker Corporation | $676.68 | 2019-2025 | Mako, Insignia, Gamma |
| Smith+Nephew, INC. | $314.04 | 2019-2022 | |
| Medical Device Business Services, INC. | $267.03 | 2023 | Bristow Latarjet |
| Fidia Pharma USA INC. | $72.65 | 2023-2024 | Hymovis, Hyalgan, Triluron |
| Orthogenrx INC. | $17.49 | 2019 | |
| Bioventus LLC | $17.41 | 2019 | |
| Pacira Therapeutics, INC. | $16.58 | 2019 | |
| Vericel Corporation | $15.27 | 2023 | Maci |
| Radius Health, INC. | $15.03 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Witty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.